Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 391 AL 405

Risks and benefits of current and novel drugs to treat agitation in Alzheimer's disease

Herrmann N, Wang HJ, Song BX, Bawa KK, Lanctôt KL.

Expert Opin Drug Saf. 2022 Oct;21(10):1289-1301. doi: 10.1080/14740338.2022.2136162. Epub 2022 Oct 20.

Adjudicating Mild Cognitive Impairment Due to Alzheimer's Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical Trial

Schneider LS, Bennett DA, Farlow MR, Peskind ER, Raskind MA, Sano M, Stern Y, Haneline S, Welsh-Bohmer KA, O'Neil J, Walter R, Maresca S, Culp M, Alexander R, Saunders AM, Burns DK, Chiang C.

J Prev Alzheimers Dis. 2022;9(4):625-634. doi: 10.14283/jpad.2022.72.

Observational studies in Alzheimer disease: bridging preclinical studies and clinical trials

Brenowitz WD, Yaffe K.

Nat Rev Neurol. 2022 Dec;18(12):747-757. doi: 10.1038/s41582-022-00733-7. Epub 2022 Oct 31.

Genistein effect on cognition in prodromal Alzheimer's disease patients. The GENIAL clinical trial

Viña J, Escudero J, Baquero M, Cebrián M, Carbonell-Asíns JA, Muñoz JE, Satorres E, Meléndez JC, Ferrer-Rebolleda J, Cózar-Santiago MDP, Santabárbara-Gómez JM, Jové M, Pamplona R, Tarazona-Santabalbina FJ, Borrás C.

Alzheimers Res Ther. 2022 Nov 4;14(1):164. doi: 10.1186/s13195-022-01097-2.

Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review

Coley N, Giulioli C, Aisen PS, Vellas B, Andrieu S.

Ageing Res Rev. 2022 Dec;82:101777. doi: 10.1016/j.arr.2022.101777. Epub 2022 Nov 4.

Effects of Kami Guibi-tang in patients with mild cognitive impairment: study protocol for a phase III, randomized, double-blind, and placebo-controlled trial

Shin HY, Yim TB, Heo HM, Jahng GH, Kwon S, Cho SY, Park SU, Jung WS, Moon SK, Ko CN, Park JM.

BMC Complement Med Ther. 2022 Dec 2;22(1):318. doi: 10.1186/s12906-022-03805-9.

Ecological Effects of VR-Based Cognitive Training on ADL and IADL in MCI and AD patients: A Systematic Review and Meta-Analysis

Son C, Park JH.

Int J Environ Res Public Health. 2022 Nov 29;19(23):15875. doi: 10.3390/ijerph192315875.

Circulatory GSK-3β: Blood-Based Biomarker and Therapeutic Target for Alzheimer's Disease

Kumari S, Singh A, Singh AK, Yadav Y, Bajpai S, Kumar P, Upadhyay AD, Shekhar S, Dwivedi S, Dey AB, Dey S.

J Alzheimers Dis. 2022;85(1):249-260. doi: 10.3233/JAD-215347.

Probiotic supplementation demonstrates therapeutic potential in treating gut dysbiosis and improving neurocognitive function in age-related dementia

Meng HYH, Mak CCH, Mak WY, Zuo T, Ko H, Chan FKL.

Eur J Nutr. 2022 Jun;61(4):1701-1734. doi: 10.1007/s00394-021-02760-4. Epub 2022 Jan 10.

Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer's disease: a randomized trial

Kellar D, Register T, Lockhart SN, Aisen P, Raman R, Rissman RA, Brewer J, Craft S.

Sci Rep. 2022 Jan 25;12(1):1346. doi: 10.1038/s41598-022-05165-3.

Challenges and hopes for Alzheimer's disease

Tatulian SA.

Drug Discov Today. 2022 Apr;27(4):1027-1043. doi: 10.1016/j.drudis.2022.01.016. Epub 2022 Feb 1.

MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets

Liu S, Fan M, Zheng Q, Hao S, Yang L, Xia Q, Qi C, Ge J.

Biomed Pharmacother. 2022 Apr;148:112681. doi: 10.1016/j.biopha.2022.112681. Epub 2022 Feb 15.

Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium

Sexton C, Solis M, Aharon-Peretz J, Alexopoulos P, Apostolova LG, Bayen E, Birkenhager B, Cappa S, Constantinidou F, Fortea J, Gerritsen DL, Hassanin HI, Ibanez A, Ioannidis P, Karageorgiou E, Korczyn A, Leroi I, Lichtwarck B, Logroscino G, Lynch C, Mecocci P, Molinuevo JL, Papatriantafyllou J, Papegeorgiou S, Politis A, Raman R, Ritchie K, Sanchez-Juan P, Sano M, Scarmeas N, Spiru L, Stathi A, Tsolaki M, Yener G, Zaganas I, Zygouris S, Carrillo M.

Alzheimers Dement. 2022 Oct;18(10):1957-1968. doi: 10.1002/alz.12588. Epub 2022 Feb 20.

Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium

Quiroz YT, Solis M, Aranda MP, Arbaje AI, Arroyo-Miranda M, Cabrera LY, Carrasquillo MM, Corrada MM, Crivelli L, Diminich ED, Dorsman KA, Gonzales M, González HM, Gonzalez-Seda AL, Grinberg LT, Guerrero LR, Hill CV, Jimenez-Velazquez IZ, Guerra JJL, Lopera F, Maestre G, Medina LD, O'Bryant S, Peñaloza C, Pinzon MM, Mavarez RVP, Pluim CF, Raman R, Rascovsky K, Rentz DM, Reyes Y, Rosselli M, Tansey MG, Vila-Castelar C, Zuelsdorff M, Carrillo M, Sexton C.

Alzheimers Dement. 2022 Sep;18(9):1677-1686. doi: 10.1002/alz.12589. Epub 2022 Feb 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias